Literature DB >> 27855148

Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse - New York, 2008-2016.

William Eggleston, Jeanna M Marraffa, Christine M Stork, Maria Mercurio-Zappala, Mark K Su, Rachel S Wightman, Karen R Cummings, Joshua G Schier.   

Abstract

Loperamide is an over-the-counter antidiarrheal with opioid-receptor agonist properties. Recommended over-the-counter doses (range = 2-8 mg daily) do not produce opioid effects in the central nervous system because of poor oral bioavailability and P-glycoprotein efflux* of the medication (1); recent reports suggest that large doses (50-300 mg) of loperamide produce euphoria, central nervous system depression, and cardiotoxicity (2-4). Abuse of loperamide for its euphoric effect or for self-treatment of opioid withdrawal is increasing (5). Cases of loperamide abuse reported to the Upstate New York Poison Center and New York City Poison Control Center were analyzed for demographic, exposure, clinical, and laboratory characteristics. Cases of intentional loperamide abuse reported to the National Poison Database System (NPDS) also were analyzed for demographic, dose, formulation, and outcome information.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27855148     DOI: 10.15585/mmwr.mm6545a7

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  Loperamide abuse.

Authors:  Tony Antoniou; David N Juurlink
Journal:  CMAJ       Date:  2017-06-12       Impact factor: 8.262

2.  A Rising Concern of Loperamide Abuse: A Case Report on Resulting Cardiac Complications.

Authors:  Amit Sapra; Priyanka Bhandari; Supriya Gupta; Shashank Kraleti; Ronak Bahuva
Journal:  Cureus       Date:  2019-12-06

3.  Loperamide-Induced Torsades de Pointes.

Authors:  Emmanuel Isang; Laylan Shali; Charles B Morris; Jeremy Mahlow
Journal:  Cureus       Date:  2021-12-09

Review 4.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22

5.  Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.